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Abstract 
      Hedyotiscorymbosa (L.) Lamk produces ursolic acid, an anti-proliferative cancer cell agent 
which inhibits the progressivity of oral cancer by inhibits proliferation and angiogenesis of cancer 
cells thus induces cancer cell apoptosis.  
      To determine the potency of Hedyotiscorymbosa (L.) Lamk in different doses (375, 750, and 
1500 mg/kg).   
25 Rattus novergicus constituted the research sample. They were divided into four groups:      
      Treatment Group 1 receiving a 375mg/kg dose, Treatment Group 2 administered a 750 mg/kg 
dose, Treatment Group 3 given a 1500mg/kg dose and Treatment Group 4 receiving only distilled 
water. Oral cavities were induced intramuscularly by 8mg/kg doses of benzopyrene twice a week 
for four weeks to induce cancer. Hedyotiscorymbosa (L.) Lamk was administered orally for 10 days.   
       All samples were acclimatized to allow performance of HPA examination. HE was used to 
examine the proliferation of cancer cells. IHC was used to determine caspase-3. Data analyzed by 
ANOVA.   
       There were significant differences in cancer cell and capillary proliferation between the control 
and treatment groups. The most significant decrease in cancer cells proliferation and highest 
caspase-3 expression was found in the group receiving a dose of 750 mg/kg.   
       Hedyotiscorymbosa (L.) Lamk extract could decrease cancer cell and capillary proliferation,  
thereby increasing apoptosis.  
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 Introduction 
 
 Cancer is the most common cause of 
mortality and morbidity around the world. In 
Indonesia, it ranks as the fifth largest cause of 
mortality.1 In the United States, 3% of the 1 
million annual cases are related to cancer of the 
oral cavity and oropharynx.2 Cancer is the third 
leading cause of death in the United Arab 
Emirates (UAE). Data from the UAE ministry of 
health indicates that cancer accounts for 
approximately 500 death per year.3  
 Head and neck cancer most common 
cancer worldwide. The most common type of 
Head and Neck cancer was Oral Squamous 
Carcinoma almost 90% of the cases.. In 
Indonesia, this type of cancer is common. The 
late diagnosis of cancer is about more than 
14,000 cases were suffered.4 A range of 
intensive cancer treatments have been 
undertaken including; surgery, chemotherapy, 
radiation therapy, immunotherapy, and 
pharmacotherapy. Thus, approaches of new 
surgical techniques, adjuvant therapy and 
molecular targeted therapy are urgently needed 
as to increase the number of cancer patient 
survivals. RNR has an essential role in 
converting ribonucleoside diphosphate to 2-
deoxyribonucleoside diphosphate to maintain 
homeostasis of nucleotide pools. RNR in DNA 
synthesis and repair had found to be an attractive 
target for anticancer agents.5 However, no 
definitive results exist, a fact rendering alternative 
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cancer treatments very important.6 One of these, 
Hedyotiscorymbosa (L.) Lamk, is widely 
accepted to be a potential anti-cancer agent. 
Febriansah et al. stated that Hedyotiscorymbosa 
(L.) Lamk extract produces anti-proliferative 
effects against liver cancer cells, yet its impact on 
oral cavity cancer remains unknown.7 
  Free radical compounds are highly 
reactive to body cells causing mutations in 
"proto-oncogenes" and "suppressor genes" 
which contribute to the regulation of cell 
proliferation and apoptosis. This means that if 
there is a mutation in the gene, proliferation will 
be uncontrolled and apoptosis will be inhibited, 
thereby, increasing the likelihood of cancer 
occurring.8,9,10 Cancer can also develop its own 
blood vessels, or angiogenesis, as a means of 
becoming more progressive. This results in the 
imbalance between cell proliferation and 
apoptosis, as well as the angiogenesis process, 
both of which accelerate cancer’s 
progressiveness.10,11,12 
Hedyotiscorymbosa (L.) Lamk is generally 
accepted to be a wild plant. It contains a group of 
terpenoid compounds that have potential as an 
herbal drug. These compounds contain ursolic 
acid that,  at a dose of 750 mg/kg can inhibit liver 
cancer.13,14 Ursolic acid has the potential to 
interfere with cell cycle regulation by inhibiting it 
between phases G to S, it restricts cell 
proliferation.15 In addition, one particular piece of 
research posits that ursolic acid is capable of 
creating progressive barriers to gastric cancer by 
rendering cyclin/CDKS inactive. Ursolic acid also 
induces apoptosis in the extrinsic pathway 
through TRAIL or necrosis tumor factor-related 
apoptosis that induces ligand16. TRAIL works 
specifically in inducing apoptosis in cancer cells, 
but not in normal ones. Ursolic acid then 
activates caspase whose function is that of a pro-
apoptosis enzyme17. In angiogenesis, the ursolic 
acid content of Hedyotiscorymbosa (L.) Lamk 
has a role in inhibiting ERK pathwayand the 
expressions of VEGF and bFGF.18,19 
This research aims to determine the potency of 
Hedyotiscorymbosa (L.) Lamk extract as an 
inhibitor of oral cancer cells and in the anti-
proliferation of such cells by increasing apoptosis 
through caspase-3 expression and decreasing 
the number of new blood vessels. It is hoped that 
the research reported here, ultimately, represents 
a contribution to the development of oral cancer 
treatment. 
   Materials and methods 
 
The research was a laboratory-based 
experimental investigation incorporating posttest-
only control group design approved through 
ethical clearance from the Committee of Ethical 
Clearance of Health Research, Faculty of 
Dentistry, Universitas Airlangga (No. 127/ 
KKEPK.FKG/IX/2014). There were four groups: 
Treatment Group 1, Treatment Group 2, 
Treatment Group 3, and the Control Group. The 
research sample was a 2-3 month old, healthy, 
male Rattus Novergicus weighing 160-200 grams. 
During the investigation, each treatment was 
replicated on six occasions. Hedyotiscorymbosa 
(L.) Lamk extract was administered in three 
distinct doses: 375 mg/kg, 750 mg/kg, and 1500 
mg/kg. 
 Data obtained was analyzed using the 
normal distribution of one sample. A Kolmogorov-
Smirnovtest, Levene's homogenity test was then 
conducted to establish whether the variant data 
was homogeneous with p = 0240 (p> 0.05). The 
distribution of the data was confirmed as normal 
and homogeneous. Therefore, the data was 
subsequently tested using One-Way ANOVA. 
Based on the results, there was a significant 
difference to the value of p = 0.000 (p <0.05) 
which led to a Post Hoc Test being conducted by 
means of a Tukey HSD. 
Preparation of Hedyotiscorymbosa (L.) 
Lamk extract 
 Hedyotiscorymbosa (L.) Lamk leaves 
were dried and pulverized in a blender, before 
being filtered to produce a powder. A large 
column of the resulting powder was soaked in 
96% ethanol by means of a macerator tool over a 
period of 72 hours. The solvent was then 
removed and evaporated, at 40oC, within a 
rotary vacuum evaporator to produce its extract. 
The latter was then mixed with distilled water at a 
ratio of 1:1. 
Oral cancer induction and 
Hedyotiscorymbosa (L.) Lamk extract 
treatment 
 The cancer was induced by administering 
benzopyrene to all sample groups. Benzopyrene, 
in the form of a powdered dose of 8 mg/kg, was 
dissolved in olivarum olium at a ratio of 2:11 17. 
The introduction of 0.7 ml benzoyrene was 
effected by injecting it with a syringe 2-3 mm in 
depth into the intraoral buccal mucosa of the rats 
over a period of four consecutive weeks.  
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After the cancer had been induced, 
Hedyotiscorymbosa (L.) Lamk extract was added, 
together with distilled water, to the treatment 
groups in the following approximate amounts; 
Treatment Group 1 - 375 mg/kg, Treatment 
Group 2 - 750 mg/kg, and Treatment Group 3 -
1500 mg/kg. Meanwhile, the Control Group was 
administered distilled water alone. The sample 
was injected twice a week. The extract was 
managed orally in the amount of 0.17ml every 
day for a period of 10 days18 
 A tissue fixation process was conducted 
in two stages. First, the tissue was soaked in 
Buffered Neutral Formalin solution (10% BNF 
with pH 6.5 – 7.5) at a ratio of 1:10. An auto 
technician processed the tissue. 4μm-thick 
paraffin blocks were cut. Cancer cell proliferation 
and capillary examination were conducted by 
means of HE (Hematoxyllin eosin) staining 
technique. Expression of caspase-3 used with 
caspase-3 monoclonal antibody was examined 
by means of immunohistochemistry staining. The 
counterstain was used as hematoxyllin (n=6 for 
each group). 
 
Results 
  
In this research, 24 mice developed 
mandibular gland cancer. The average degree of 
cancer cell proliferation in the control and 
treatment groups is shown in Figure 1. Based on 
the data, it seems that the average number of 
cancer cells in the Control Group was the highest, 
while that of Treatment Group 2 was lower than 
those of Treatment Groups 1 and 3 (Table 1).  
 
 
Figure 1. Cancer cells (shown in black arrow) in 
control (a), treatment 1 (b), treatment 2 (c), and 
treatment 3 (d) group. 
 
Table 1. The cancer cell numbers in each group. 
 
It seems that the average number of new 
blood vessels in the Control Group was far higher 
than that of the treatment groups, with Treatment 
Group 2 being the lowest (Figure 2 and Table 2). 
 
 
Figure 2. New blood vessel (shown in black 
arrow) in control (a), treatment 1 (b), treatment 2 
(c), and treatment 3 (d) group. 
 
 
Table 2. The number of new blood vessels in 
each group. 
 
 The ethanol extract of 
Hedyotiscorymbosa (L.) Lamk at a dose of 750 
mg/kg significantly inhibited the formation of new 
blood vessels in Treatment Group 2. Thus, a 
dose of such volume could be considered to be 
the most effective when compared to Treatment 
Group 1 and 2’s respective doses of 375 mg/kg 
and 1500 mg/kg. 
 The average number of cancer cells 
expressing caspase-3 across all groups is shown 
in Figure 3. Based on the data shown there, the 
highest average number of cancer cells 
expressing caspase-3 was in the apoptosis of 
Treatment Group 2 (see Table 3). 
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Figure 3. Caspase 3 expression (shown in black 
arrow) in control (a), treatment 1 (b), treatment 2 
(c), and treatment 3 (d) group. 
 
 
Table 3. The number of caspase-3 expression in 
each group. 
 
Discussion 
  
Cancer is considered to be the leading 
cause of mortality and morbidity in the world. 
Cancer cells can invade biological tissues by 
invasion and metastasis. Abnormal protein 
function can damage DNA and p53 gene 
mutation, controlling cell proliferation. Therefore, 
uncontrolled cell proliferation and inhibited 
apoptosis can lead to cancer. However, normal 
cells will only develop into malignant ones if the 
condition of the body's immune system 
deteriorates. In other words, the immune system 
tends to help the process of initiation, promotion 
and progression in cancer formation.20,21,22 
The research presented here was purely 
experimental in nature and intended to discover 
the benefits of Hedyotiscorymbosa (L.) Lamk 
extract in preventing and curing cancer. 
According to Febriansah et al, 
Hedyotiscorymbosa (L.), Lamk extract contains 
ursolic acid which plays an anti-proliferative role 
with regard to liver cancer cells. In addition, 
according to Jaki et al, ursolic acid acts as an 
immunomodulator, anti-inflammatory, and 
antioxidant. Therefore, ursolic acid could 
potentially play a major role in the development 
of cancer therapies.16 
During the research project reported here, 
cancer developed in the lymph gland. Informed 
opiniongenerally accepts that the immune system 
exerts a greater of lesser degree of influence on 
the incidence of cancer.23 The injected 
benzopyrene represented a highly reactive 
compound potentially capable of suppressing the 
immune system. Therefore, it could lead to 
cancer in the sub-mandibular gland.24,25. 
Benzopyrene is an organic compound 
with a specific molecular formula, C20H12, falling 
within the extremely toxic class of polycyclic 
aromatic hydrocarbons (PAH). In the living body, 
benzopyrene intercalates into Deoxyribo Nucleic 
Acid (DNA) that can, potentially, interfere with the 
process of DNA transcription. Therefore, the 
disruption of the transcription process could 
serve as a tumor initiator and mediator.26,27  
Furthermore, Benzopyrene demonstrates 
structural similarities with nucleobases such as 
adenosine, thymine, guanine and cytosine. This, 
conceivably, makes it easy for benzopyrene to 
insert itself into DNA strands.28,29 As a result, 
DNA function will be disrupted and if the damage 
cannot be repaired the cell will give rise to cancer.  
Benzopyrene is commonly known as a 
hydrophobic compound lacking methyl structure 
or other reactive properties to be converted to a 
more polar compound. It is very difficult for the 
body to excrete this compound, causing 
accumulation in body tissues such as the lymph, 
adipose, liver and kidney tissue. As a result, 
exposure to high levels of benzopyrene would 
cause the suppression of the immune system, 
giving rise to cancer.30 
In general, the result shows that the 
average number of cancer cells in the group 
treated with Hedyotiscorymbosa (L.) Lamk 
extract is lower than that in the control group. 
This contrast was due to the role of 
Hedyotiscorymbosa (L.) Lamk extract that acts 
as an anti-proliferation agent. 
Hedyotiscorymbosa (L.) Lamk extract contains 
ursolic acid that is considered to be an anti-
proliferant of cancer cells through the inhibition of 
the STAT3 pathway (Signal Transducers and 
Activators of Transcription-3).31  
Ursolic acid binds to estrogen receptors 
on the macrophage surface which then activates 
an intracellular transduction signal and causes 
the phosphorylation and degradation of IkB 
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(Inhibitor k Beta). The degradation of IkB could 
enable NF-kB (Nuclear Factor kappa B) to be 
translocated into the nucleus. Once there, NF-kB 
induces the transcription of genes that control 
various chemokines, immune receptors and 
cytokines such as IL-12. The induction of IL-12 
stimulates the production of IFN-. However, it 
could also prevent the proliferation of Th2,which 
produces IL-10 through a process of 
homeostasis.31,32 
IFN- could re-activate macrophages that 
give rise to the phagocytosis of cancer cells. 
Meanwhile, the reduction of IL-10, which is a 
cytokine that works on STAT3 pathways, would 
inhibit such pathways through JAK-2 (Janus 
Activated Kinase-2).33 Ursolic acid is actually 
capable of inhibiting JAK-2, thereby preventing 
the phosphorylation of proteins used in the 
activation of STAT3. The inhibition of STAT3 
pathways would then lead to the disruption of the 
regulation system of gene products (such as 
cyclin D1, Bcl-2, Bcl-xl, surviving, Mcl-1, and 
vascular endothelial growth factor) and the 
modulation of cell proliferation.17,33 
STAT3 is a signal transduction that acts 
as a regulator of gene products such as cyclin D1. 
Thus, the inactivation of STAT3 pathways would 
lead to the disruption of the nuclear translocation 
rendering it unable to play a role in regulating 
cyclin D1 and modulating cell proliferation. Cyclin 
D1 is an active form of Cyclin Dependent Kinase 
(CDK) required by cells to perform mitosis and 
plays a role in the G1 phase whose purpose is to 
prepare for the DNA replication phase. When this 
phase is interrupted cell proliferation could be 
inhibited.33,35 
In the G1 phase, the p53 gene was 
involved in the transactivation of the p21 protein. 
The function of the p21 gene is to suppress the 
activity of CDK-Cyclin complexes. A checkpoint 
occurred at the end of the G1 phase before 
entering the S phase. Its function was to create 
the possibility for the cells to repair themselves 
(apoptosis). Apoptosis is recognized by the 
increase of caspase-3 expression, known as the 
executor of dead cells. The formation of new 
blood vessels could be decreased by inhibiting 
ERK (Extra Celular Signal Regulatory Kinase), 
causing a reduction in HIF-α (hypoxia inducible 
factor). Finally, apoptosis creates VEGF barriers 
resulting in the newly formed blood vessels being 
few in number.36 
 
Conclusions 
 
The conclusion of this research is that 
ethanol extract of Hedyotiscorymbosa (L.) Lamk 
could conceivably reduce the progression of oral 
cancer in the lymph gland of wistar strain rats 
induced by benzopyrene with the most effective 
dose being one of 750 mg/kg.  
Further research is required incorporating 
the use of pure ursolic acid compounds to 
decrease the progression of cancer in the oral 
cavity. Additional research also needs to be 
conducted, regarding to the efficacy of ursolic 
acid in enhancing immune system as an 
immunomodulator. 
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